Metabolomic Strategy for Studying the Intervention and the Synergistic Effects of the Shexiang Baoxin Pill for Treating Myocardial Infarction in Rats

Figure 6

PLS-DA score plots of rat serum on day 15 in positive and negative modes. (a) PLS-DA score plot of rat serum of the SFSBP group in positive mode (𝑅²𝑋_(cum)=0.596, 𝑅²𝑌_(cum)=0.977, 𝑄²𝑌_(cum)=0.573); (b) PLS-DA score plot of rat serum of the SFSBP group in negative mode (𝑅²𝑋_(cum)=0.516, 𝑅²𝑌_(cum)=0.975, 𝑄²𝑌_(cum)=0.583).

(a)

(b)